Analysts at the major investment banks are generally in agreement with Sanofi CEO Paul Hudson’s assessment of the firm’s Consumer Healthcare (CHC) separation plan as a “win win.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?